Tetra Bio-Pharma could be a new partner!Yesterday, TETRA BIO-PHARMA ANNOUNCED GRANTING OF U.S. PATENT FOR TREATMENT OF INTERSTITIAL CYSTITIS. The important factor here is that the
new oral treatment ( a cannabinoid treatment) could benefit of CZO's beta glucan inhalable technology.